Related references
Note: Only part of the references are listed.Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma
Evan J. Lipson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Melanoma in Immunosuppressed Patients
Agnieszka W. Kubica et al.
MAYO CLINIC PROCEEDINGS (2012)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Phase II study of extended-dose temozolomide in patients with melanoma
Petra Rietschel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis
HB Wang et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
